Buy-rated reports

511 tickers rated Buy
NewestHighest Score Ranks all reports in this rating group by score, highest first.
Energy Transfer LP
ET·Energy
A ★★★★Buy
Current$19.19
Target$26.95
Return+40.4%
Nov 6, 2026

Energy Transfer offers attractive income and upside from undervalued midstream infrastructure and rising natural gas demand, although substantial debt and aggressive capital spending could constrain per-unit returns.

Score
84
Ero Copper Corp.
ERO·Materials
A ★★★★Buy
Current$30.82
Target$41.04
Return+33.2%
Nov 5, 2026

Ero Copper combines expanding copper production, strong cash generation, and improving leverage with an attractive earnings valuation, but commodity-price volatility and mining execution risks could undermine sustainable returns.

Score
84
Cognizant Technology Solutions Corporation
CTSH·Technology
A ★★★★Buy
Current$65.11
Target$73.20
Return+12.4%
Nov 1, 2026

Cognizant offers profitable enterprise IT services, strong cash returns and an attractive valuation with AI-driven transformation upside, although automation-related revenue pressure and limited organic growth threaten its long-term earnings power.

Score
84
DexCom, Inc.
DXCM·Healthcare
A ★★★★Buy
Current$82.29
Target$95.20
Return+15.7%
Nov 1, 2026

Dexcom offers recurring CGM revenue, high capital returns, and substantial long-term diabetes-monitoring growth potential at a compressed historical valuation, although Abbott competition and reimbursement constraints could limit upside.

Score
84
Textron Inc.
TXT·Industrials
A ★★★★Buy
Current$85.70
Target$100.80
Return+17.6%
Nov 1, 2026

Textron offers established aviation franchises, growing defense opportunities and attractive normalized earnings valuation, although aircraft-production inefficiencies and military program execution remain significant risks.

Score
84
Eli Lilly and Company
LLY·Healthcare
A ★★★★Buy
Current$1,417.54
Target$1,480.80
Return+4.5%
Nov 1, 2026

Eli Lilly combines a powerful obesity-treatment franchise, exceptional capital efficiency, and a promising drug pipeline, but premium valuation and dependence on tirzepatide leave investors exposed to pricing and competitive setbacks.

Score
84
EMCOR Group, Inc.
EME·Industrials
A ★★★★Buy
Current$679.55
Target$782.00
Return+15.1%
Nov 1, 2026

EMCOR can compound earnings through mission-critical electrical and mechanical construction demand, strong project execution, and disciplined capital allocation, but its growth premium remains vulnerable to a slowdown in data-center investment.

Score
84
AerCap Holdings N.V.
AER·Industrials
A ★★★★Buy
Current$158.52
Target$186.30
Return+17.5%
Nov 1, 2026

AerCap combines dominant aircraft leasing scale, strong returns on equity, and aggressive share buybacks with an attractive earnings multiple, although cyclical aircraft values and substantial financial leverage remain important risks.

Score
84
PPG Industries, Inc.
PPG·Materials
A ★★★★Buy
Current$119.52
Target$129.75
Return+8.6%
Oct 31, 2026

PPG offers differentiated coatings technology, improving cash generation and potential valuation rerating as margins recover, although industrial cyclicality and raw-material inflation could constrain earnings growth.

Score
84
Graco Inc.
GGG·Industrials
A ★★★★Buy
Current$67.44
Target$78.20
Return+16.0%
Oct 31, 2026

Graco combines a durable industrial-equipment moat, strong cash generation and historically compressed valuation multiples, although cyclical demand, margin pressure and acquisition integration could delay earnings recovery.

Score
84
CME Group Inc.
CME·Financials
A ★★★★Buy
Current$303.14
Target$319.92
Return+5.6%
Oct 31, 2026

CME combines deeply entrenched derivatives-market liquidity with exceptional cash generation and attractive shareholder distributions, although premium valuation and emerging competition limit its margin of safety.

Score
84
Morningstar, Inc.
MORN·Financials
A ★★★★Buy
Current$222.54
Target$243.20
Return+9.3%
Oct 30, 2026

Morningstar combines defensible financial-data franchises, high returns on capital, and expanding cash generation at a reasonable valuation, although AI competition, uneven segment growth, and acquisition-related leverage remain material risks.

Score
84